JMS-14282-71869 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-25
Registered in v-safe
2021-03-25
Dose 1 — Pfizer-BioNTech
2021-03-25
Survey response — day 0, dose 1
MedDRA: Feeling hot, Limb discomfort — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Heavy and hot arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-03-28
Survey response — days 1–6 daily, dose 1
MedDRA: Paranasal sinus hypersecretion — Feeling: Fair · Headache

Free text: Sinus drainage.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-08
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-15
Dose 2 — Pfizer-BioNTech
2021-04-15
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Fever · None

Adult check-in
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · None

Adult check-in
2021-04-18
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary pain, Injection site pain — Feeling: Good · Site: Pain

Free text: Injection site pain moved to armpit area

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary pain — Feeling: Good

Free text: Armpit soreness still

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-22
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-29
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-06
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-13
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-20
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-15
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-28
Dose 3 — Pfizer-BioNTech
2021-12-28
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-12-29
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-30
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Diarrhea, Abdominal pain

Free text: Lymph node swelling

MedDRA releases: 2024-11 · check-in free text available
2022-01-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2022-01-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-04
Health check-in — day 7, dose 3
Feeling: Good · Headache

Adult check-in
2022-01-11
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-18
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-25
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-03
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-31
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-28
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-28
Survey response — 12 months, dose 3
MedDRA: Dyspnoea, Fatigue, Malaise, Pain, Secretion discharge — Feeling: Fair

Free text: COVID symptoms. Mucus, shortness of breath, achy, tired.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-25	Pfizer-BioNTech
2	2021-04-15	Pfizer-BioNTech
3	2021-12-28	Pfizer-BioNTech	No

Free text

Release 6 — day 0, dose 1

2021-03-25

Systemic reaction (other): Heavy and hot arm

Release 6 — days 1–6 daily, dose 1

2021-03-28

Systemic reaction (other): Sinus drainage.

Release 7 — days 1–6 daily, dose 2

2021-04-18

Systemic reaction (other): Injection site pain moved to armpit area

2021-04-19

Systemic reaction (other): Armpit soreness still

Release 10 — days 1–6 daily, dose 3

2021-12-30

Systemic reaction (other): Lymph node swelling

Release 12 — 12 months, dose 3

2022-12-28

Symptoms: COVID symptoms. Mucus, shortness of breath, achy, tired.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dyspnoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Malaise	·	·	✓
SD	Pain	·	·	✓
SD	Secretion discharge	·	·	✓
SRO	Axillary pain	✓	✓	✓
SRO	Feeling hot	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Limb discomfort	✓	✓	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Paranasal sinus hypersecretion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release